Skip to content
Screener

Sionna Therapeutics SION Market capitalization

Market capitalization at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$126.07B+9.0%
AbbVie logo
AbbVieABBV
$444.6B+35.6%
Achieve Life Sciences logo
Achieve Life SciencesACHV
$156.53M+69.0%
Septerna, Inc. logo
Septerna, Inc.SEPN
$1.51B+216%
RFL
Rafael Holdings, Inc.RFL
$66.06M+5.2%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$475.29M+218%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Enterprise value$147.55M-82.7%

Returns & leverage

See full
Return on equity-26.7%—
Debt / equity0×0.0×
Current ratio22.6×-6.1×

Where this comes from

Computed from the period-end share price: $1.8B.

The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 7:17 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-033876

FAQ

What is Sionna Therapeutics's market capitalization?
Sionna Therapeutics (SION) reported market capitalization of $1.8B in Q1 2026.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Ask your AI about Sionna Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude